Guru Ownership Trend
Guru Analysis for Lexeo Therapeutics, Inc. (LXEO)
Lexeo Therapeutics, Inc. (LXEO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $14.01 M.
Top institutional holders include Steven Cohen and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $107,323.49 net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 45.9%. Conversely, Cliff Asness reduced exposure by 3.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Lexeo Therapeutics, Inc. (LXEO)
Major holders include Steven Cohen ($18.81 M), Cliff Asness ($3.35 M), Renaissance Technologies (RenTech) ($2.16 M). According to the latest reported data, 3 tracked investment managers collectively hold approximately 2.45 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $107,323.49, with 1 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited LXEO. The total reported sell value was $572,603.48.
Yes, 0 managers opened new positions in LXEO, and 1 increased their existing holdings. The total reported buy value was $679,926.97.